The present invention provides novel compounds that act to affect positive amino acid receptors and are useful in the treatment of aneurological and psychiatric disorders. Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein X is (CH2) n; R2 is CO2R4 and R3 is hydrogen or R2 is hydrogen and R3 is CO2R4; R 1 and R 4 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, aryl or arylalkyl; andn meaning 1. ŕ
展开▼
机译:本发明提供了新颖的化合物,该化合物起影响阳性氨基酸受体的作用并且可用于治疗神经病学和精神病学疾病。式(I)化合物及其药学上可接受的盐,其中X为(CH 2)n; R 2为CO 2 R 4且R 3为氢或R 2为氢且R 3为CO 2 R 4; R 1和R 4各自独立地为氢,C 1-10烷基,C 2-10烯基,芳基或芳基烷基; andn的意思是1.ŕ
展开▼